Andreas Dr. Reindl

Chief Operating Officer @Allozymes

Mannheim, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2025 — Present

Chief Operating Officer @Allozymes

View department →

SG

EDUCATION

N/A

University of Arizona

Biochemistry and Molecular Biology

N/A

University of Tübingen

Ph.D, Biochemistry and Molecular Biology

N/A

INSEAD

Executive Management Program, Negotiation Dynamics

N/A

Max Planck Society

Biochemistry and Molecular Biology

ABOUT ANDREAS DR. REINDL

Expert in bringing technology-based products to market in complex international partner scenarios by deeply understanding customer needs as well as leading customers in their respective industries, e.g, biotechnology, renewable energies, agriculture, personal health, paper and pulp, specialty chemicals. Track-record in innovation development and management.Highly versatile and experienced general manager in the chemical industry with focus on biotechnological applications, e.g, in biofuels, industrial enzymes, agricultural solutions, as well as food, cosmetics and personal health. Profound expertise in incubating and running P&L responsibilities with more than 150 million Euro revenue with a business footprint from innovation to commercialization. Covering responsibilities for New Business, Corporate and Technology Strategy, R&D and Product Development, Business Development, M&A and Sales.20+ years of experience in business model development, restructuring and organizational transformation.Comprehensive experience in leading cross-functional und international organizations with excellent stakeholder management skills and the ability to drive decision making processes and their implementation. Entrepreneurial spirit, highly genuine, reliable and trustworthy with profound C-suite stakeholder management experience. Achievements• Successful ramp-up of new businesses for decarbonized biofuels in Europe and the US, sustainable products based on renewable feedstocks and bio-based functional ingredients with one of them elected among the 100 most influential innovations of the future. Numerous granted patents. Introduction in the market with global partners in the Personal Health market segment, thus incubating a sizeable market success.• New and improved organizational structures and processes implemented as part of a long-term 0.5 billion Euro strategy jointly developed with operational and regional business units, as head of strategy and processes by successfully managing stakeholders with measurable short-term gains.• Founding member of the successful plant biotechnology (BASF Plant Science, business unit with more than 500 million Euro revenue today) responsible for research topics, strategy and operational implementation as a separate business within the BASF Group.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Andreas Dr. Reindl — Chief Operating Officer at Allozymes in Mannheim, DE | Unifers